Marie Poegh,Reinhard Franzen,Wolfgang Eder,Jeff Frick
申请号：
US13757060
公开号：
US20130225542A1
申请日:
2013.02.01
申请国别(地区):
US
年份:
2013
代理人:
摘要：
This invention describes the use of a therapeutic gestagen (e.g., drospirenone, cyproterone acetate, dienogest) for the production of a pharmaceutical agent for the treatment of premenstrual dysphoric disorder (PMDD), optionally in combination with a natural or synthetic estrogen (e.g., estradiol or ethinylestradiol).
